Impact of neoadjuvant relugolix on patient-reported sexual function and bother

Overview of attention for article published in Frontiers in oncology, April 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 9,576 followers.

Impact of neoadjuvant relugolix on patient-reported sexual function and bother. https://t.co/LA9kYpbNVw

27 Apr 2024

Reply Repost Favourite

RT @willkin111: Really good to see the sexual impact of novel hormonal treatments for prostate cancer being properly investigated. Would be…

26 Apr 2024

Reply Repost Favourite

Really good to see the sexual impact of novel hormonal treatments for prostate cancer being properly investigated. Would be interesting to see relugolix vs GnRH agonists in the future https://t.co/VQuLlFKQkx

25 Apr 2024

Reply Repost Favourite

RT @sarthakshah097: Great job @JessicaHsueh923 on your publication!! Keep an eye on this all-star during #Match2025 @AmerUrological @TheAAC…

11 Apr 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.